VANGUARD GROUP INC - LANDOS BIOPHARMA INC ownership

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of LANDOS BIOPHARMA INC
ValueSharesWeighting
Q1 2023$7,151
-86.1%
23,995
-76.7%
0.00%
Q4 2022$51,555
-52.3%
103,089
-38.1%
0.00%
Q3 2022$108,000
+16.1%
166,608
+30.6%
0.00%
Q2 2022$93,000
-60.3%
127,555
-19.8%
0.00%
Q1 2022$234,000
-84.0%
159,001
-47.8%
0.00%
Q4 2021$1,463,000
-67.1%
304,798
+0.0%
0.00%
Q3 2021$4,450,000
+26.3%
304,794
-0.1%
0.00%
Q2 2021$3,524,000
+94.2%
305,185
+61.9%
0.00%
Q1 2021$1,815,000188,4600.00%
Other shareholders
LANDOS BIOPHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
OUP Management Co., LLC 1,237,667$804,0001.25%
Perceptive Advisors 14,869,915$9,665,0000.28%
RTW INVESTMENTS, LP 3,975,722$2,584,0000.06%
ArchPoint Investors 127,262$83,0000.03%
STEEL GROVE CAPITAL ADVISORS, LLC 84,500$55,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 149,000$97,0000.00%
FMR LLC 2,000$1,0000.00%
BANK OF AMERICA CORP /DE/ 16,482$11,0000.00%
WELLS FARGO & COMPANY/MN 104$00.00%
NORTHERN TRUST CORP 12,219$8,0000.00%
View complete list of LANDOS BIOPHARMA INC shareholders